Board Meetings for MARKSANS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MARKSANS | Marksans Pharma Limited | 13 Aug 2024 | MARKSANS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . | Board Meeting Intimation | |
| MARKSANS | Marksans Pharma Limited | 30 May 2024 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend | |
| MARKSANS | Marksans Pharma Limited | 13 Feb 2024 | Financial Results | To consider and approve the financial results for the period ended December 31, 2023 | |
| MARKSANS | Marksans Pharma Limited | 13 Feb 2024 | MARKSANS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| MARKSANS | Marksans Pharma Limited | 09 Nov 2023 | MARKSANS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . | Board Meeting Intimation | |
| MARKSANS | Marksans Pharma Limited | 09 Nov 2023 | Financial Results | To consider and approve the financial results for the period ended September 30, 2023 | |
| MARKSANS | Marksans Pharma Limited | 11 Aug 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 | |
| MARKSANS | Marksans Pharma Limited | 11 Aug 2023 | MARKSANS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . | Board Meeting Intimation | |
| MARKSANS | Marksans Pharma Limited | 30 May 2023 | MARKSANS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend. | Board Meeting Intimation | |
| MARKSANS | Marksans Pharma Limited | 30 May 2023 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend | |
| MARKSANS | Marksans Pharma Limited | 13 Feb 2023 | Financial Results | To consider and approve the financial results for the period ended December 31, 2022 | |
| MARKSANS | Marksans Pharma Limited | 20 Jan 2023 | Other business matters | To consider and approve allotment of fully paid-up Equity Shares having face value of Re. 1/- each against the convertible warrants on preferential basis | |
| MARKSANS | Marksans Pharma Limited | 14 Nov 2022 | Financial results | Marksans Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 | |
| MARKSANS | Marksans Pharma Limited | 13 Aug 2022 | Financial results | Marksans Pharma Limited has informed the Exchange about Board Meeting to be held on 13-Aug-2022 to consider financial statements for the period ended June 2022 | |
| MARKSANS | Marksans Pharma Limited | 08 Jul 2022 | Buyback | Marksans Pharma Limited has informed the Exchange about Board Meeting to be held on 08-Jul-2022 to consider the proposal for buyback of fully paid up equity shares of the Company upto such amount of the aggregate of Company���s paid up equity share capital and free reserves as the Board may decide in accordance with the provisions of Section 68, 69 and 70 of the Companies Act, 2013 and the SEBI (Buyback of Securities) Regulations, 2018.It is further submitted that in terms of the Company's Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of the Company for the designated person(s) is already closed w.e.f. July 01, 2022 and will remain closed till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2022. |